Pàgina inicial > Resultats de la cerca: Ringden, Olle
  Consells de cerca
Cerca simple
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Dipòsit Digital de Documents de la UAB 4 registres trobats  La cerca s'ha fet en 0.00 segons. 
1.
34 p, 950.5 KB Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies / Pasquini, Marcelo (Medical College of Wisconsin) ; Zhang, Mei-Jie (Medical College of Wisconsin) ; Medeiros, Bruno (Stanford University School of Medicine) ; Armand, Philippe (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Hu, Zhen-Huan (Medical College of Wisconsin) ; Nishihori, Taiga (H. Lee Moffitt Cancer Center and Research Institute) ; Aljurf, Mahmoud D. (King Faisal Specialist Hospital Center and Research) ; Akpek, Görgün (Banner MD Anderson Cancer Center) ; Cahn, Jean-Yves (University Hospital) ; Cairo, Mitchell S. (New York Medical College) ; Cerny, Jan (UMass Memorial Medical Center) ; Copelan, Edward A. (Carolinas HealthCare System) ; Deol, Abhinav (Wayne State University) ; Freytes, César O. (University of Texas Health Science Center San Antonio) ; Gale, Robert Peter (Imperial College London) ; Ganguly, Siddhartha (University of Kansas Medical Center) ; George, Biju (Christian Medical College) ; Gupta, Vikas (University Health Network) ; Hale, Gregory A. (All Children's Hospital) ; Kamble, Rammurti T. (Baylor College of Medicine) ; Klumpp, Thomas R. (Thomas Jefferson University Hospital) ; Lazarus, Hillard M. (University Hospitals Case Medical Center) ; Luger, Selina M. (University of Pennsylvania Medical Center) ; Liesveld, Jane L. (University of Rochester Medical Center) ; Litzow, Mark Robert (Mayo Clinic) ; Marks, David I. (University Hospitals Bristol NHS Trust) ; Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ; Norkin, Maxim (University of Florida College of Medicine) ; Olsson, Richard F. (Uppsala University) ; Oran, Betul (The University of Texas MD Anderson Cancer Center) ; Pawarode, Attaphol (University of Michigan) ; Pulsipher, Michael A. (University of Southern California Keck School of Medicine) ; Ramanathan, Muthalagu (UMass Memorial Medical Center) ; Reshef, Ran (University of Pennsylvania Medical Center) ; Saad, Ayman A. (University of Alabama at Birmingham) ; Saber, Wael (Medical College of Wisconsin) ; Savani, Bipin N. (Vanderbilt University Medical Center) ; Schouten, Harry C. (Academische Ziekenhuis) ; Ringdén, Olle (Centre for Allogeneic Stem Cell Transplantation) ; Tallman, Martin S. (Memorial Sloan Kettering Cancer Center) ; Uy, Geoffrey L. (Washington University School of Medicine) ; Wood, William A. (University of North Carolina) ; Wirk, Baldeep (Seattle Cancer Care Alliance) ; Pérez, Waleska S. (Medical College of Wisconsin) ; Batiwalla, Minoo (National Heart Lung and Blood Institute - National Institutes of Health) ; Weisdorf, Daniel J. (University of Minnesota Medical Center) ; Universitat Autònoma de Barcelona
The presence of monosomal karyotype (MK+) in acute myeloid leukemia (AML) is associated with dismal outcomes. We evaluated the impact of MK+ in AML (MK+AML, n = 240) and in myelodysplastic syndrome (MDS) (MK+MDS, n = 221) on hematopoietic cell transplantation outcomes compared with other cytogenetically defined groups (AML, n = 3360; MDS, n = 1373) as reported to the Center for International Blood and Marrow Transplant Research from 1998 to 2011. [...]
2016 - 10.1016/j.bbmt.2015.08.024
Biology of blood and marrow transplantation, Vol. 22 Núm. 2 (january 2016) , p. 248-257  
Registre complet - Creative Commons
2.
8 p, 1012.2 KB Reduced intensity conditioning increases risk of severe cGVHD : identification of risk factors for cGVHD in a multicenter setting / Afram, Gabriel (Karolinska University Hospital and Karolinska Institutet (Suecia)) ; Simón, Jose Antonio Pérez (Instituto de Biomedicina de Sevilla) ; Remberger, Mats (Karolinska University Hospital and Karolinska Institutet (Suecia)) ; Caballero Velazquez, Teresa (Instituto de Biomedicina de Sevilla) ; Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ; Piñana, Jose Luis (Hospital Clinico Universitario) ; Ringden, Olle (Karolinska University Hospital and Karolinska Institutet (Suecia)) ; Esquirol, Albert (Institut d'Investigació Biomèdica Sant Pau) ; Lopez-Corral, Lucia (Hospital Universitario de Salamanca-IBSAL) ; Garcia Cadenas, Irene (Institut d'Investigació Biomèdica Sant Pau) ; López-Godino, Oriana (Hospital Universitario de Salamanca-IBSAL) ; Malouf Sierra, Jorge 1971- (Institut d'Investigació Biomèdica Sant Pau) ; Caballero, Dolores (Hospital Universitario de Salamanca-IBSAL) ; Ljungman, Per (Karolinska University Hospital and Karolinska Institutet (Suecia)) ; Vazquez, Lourdes (Hospital Clínico Universitario (Salamanca)) ; Hägglund, Hans (Uppsala University Hospital) ; Universitat Autònoma de Barcelona
Chronic graft-versus-host disease (cGVHD) remains a major cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT). Aim is to identify risk factors for the development of cGVHD in a multicenter setting. [...]
2018 - 10.1007/s12032-018-1127-2
Medical Oncology, Vol. 35 Núm. 6 (january 2018) , p. 79  
Registre complet - Creative Commons
3.
13 p, 850.9 KB Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic Transplantation / Chhabra, Saurabh (Medical College of Wisconsin) ; Liu, Ying (Medical College of Wisconsin) ; Hemmer, Michael T. (Medical College of Wisconsin) ; Costa, Luciano (University of Alabama at Birmingham. Department of Medicine) ; Pidala, Joseph A. (H. Lee Moffitt Cancer Center and Research Institute) ; Couriel, Daniel R. (Utah Blood and Marrow Transplant Program) ; Alousi, Amin M. (University of Texas MD Anderson Cancer Center) ; Majhail, Navneet S. (Cleveland Clinic Taussig Cancer Institute) ; Stuart, Robert K. (Medical University of South Carolina) ; Kim, Dennis (Princess Margaret Cancer Center) ; Ringden, Olle (Karolinska Institutet (Estocolm, Suècia). Division of Therapeutic Immunology) ; Urbano Ispizua, Álvaro (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Saad, Ayman (University of Alabama at Birmingham) ; Savani, Bipin N. (Vanderbilt University Medical Center) ; Cooper, Brenda (University Hospitals Case Medical Center. Department of Medicine-Hematology and Oncology) ; Marks, David I. (University Hospitals Bristol NHS Trust) ; Socie, Gerard (Hôpital Saint Louis. Department of Hematology) ; Schouten, Harry C. (Academische Ziekenhuis. Department of Hematology) ; Schoemans, Helene (University Hospitals Leuven (Bèlgica)) ; Abdel-Azim, Hisham (University of Southern California Keck School of Medicine) ; Yared, Jean (University of Maryland. Greenebaum Cancer Center) ; Cahn, Jean-Yves (CHU Grenoble Alpes. Department of Hematology) ; Wagner, John (Thomas Jefferson University. Department of Medical Oncology) ; Antin, Joseph H. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Verdonck, Leo F. (Isala Clinic. Departmentt of Hematology/Oncology) ; Lehmann, Leslie (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Aljurf, Mahmoud (King Faisal Specialist Hospital and Research Centre (Aràbia Saudita)) ; MacMillan, Margaret L. (University of Minnesota Blood and Marrow Transplant Program) ; Litzow, Mark R. (Mayo Clinic Rochester. Division of Hematology and Transplant Center) ; Solh, Melhem M. (Northside Hospital. Blood and Marrow Transplant Group of Georgia) ; Qayed, Muna (Emory University School of Medicine. Department of Pediatrics) ; Hematti, Peiman (University of Wisconsin) ; Kamble, Rammurti T. (Baylor College of Medicine) ; Vij, Ravi (Washington University School of Medicine. Division of Hematology and Oncology) ; Hayashi, Robert J. (Washington University School of Medicine in St. Louis. Division of Pediatric Hematology/Oncology) ; Gale, Robert Peter (Imperial College London. Hematology Research Centre) ; Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ; Seo, Sachiko (National Cancer Research Center East) ; Hashmi, Shahrukh K (Mayo Clinic Rochester. Division of Hematology and Transplant Center) ; Nishihori, Taiga (H. Lee Moffitt Cancer Center and Research Institute) ; Teshima, Takanori (Kyushu University Hospital) ; Gergis, Usama (New York Presbyterian Hospital/Weill Cornell Medical Center. Department of Medical Oncology) ; Inamoto, Yoshihiro (National Cancer Center Hospital) ; Spellman, Stephen R. (Center for International Blood and Marrow Transplant Research) ; Arora, Mukta (University of Minnesota Medical Center) ; Hamilton, Betty K. (Cleveland Clinic Taussig Cancer Institute) ; Universitat Autònoma de Barcelona
The combination of a calcineurin inhibitor (CNI) such as tacrolimus (TAC) or cyclosporine (CYSP) with methotrexate (MTX) or with mycophenolate mofetil (MMF) has been commonly used for graft-versus-host disease (GVHD) prophylaxis after reduced-intensity conditioning (RIC) allogeneic hematopoietic cell transplantation (alloHCT), but there are limited data comparing efficacy of the 2 regimens. [...]
2019 - 10.1016/j.bbmt.2018.08.018
Biology of blood and marrow transplantation, Vol. 25 Núm. 1 (january 2019) , p. 73-85  
Registre complet - Creative Commons
4.
9 p, 823.3 KB Evaluation of prognostic factors among patients with chronic graft-versus-host disease / Pérez-Simón, José Antonio (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Afram, Gabriel (Karolinska Institutet (Estocolm, Suècia)) ; Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ; Piñana, José Luis (Institut d'Investigació Biomèdica Sant Pau) ; Caballero Velazquez, Teresa (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Ringden, Olle (Karolinska Institutet (Estocolm, Suècia)) ; Valcárcel, David (Institut d'Investigació Biomèdica Sant Pau) ; Caballero, Dolores (Hospital Universitario de Salamanca) ; Remberger, Mats (Karolinska Institutet (Estocolm, Suècia)) ; Paz, Yanira de (Hospital Universitario de Salamanca) ; Sierra, Jorge (Institut d'Investigació Biomèdica Sant Pau) ; San-Miguel, J (Hospital Universitario de Salamanca) ; Hagglund, Hans (Karolinska Institutet (Estocolm, Suècia)) ; Universitat Autònoma de Barcelona
Background Chronic graft-versus-host disease (cGVHD) is a major complication after allogeneic stem cell transplantation with an adverse effect on both mortality and morbidity. In 2005, the National Institute of Health proposed new criteria for diagnosis and classification of chronic graft-versus-host disease for clinical trials. [...]
2012 - 10.3324/haematol.2011.055244
Haematologica, Vol. 97, Núm. 8 (january 2012) , p. 1187-1195  
Registre complet -

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem